Simon Li

Simon Li is responsible for strategic planning and execution of multiple clinical stage programs to ensure quick regulatory approvals for global market launches. Previously, he was CMO, VP and other senior roles in several industry-lading companies, including Bayer, Pharmacia, Roche, Lilly, Luye Pharma and CSPC.

Simon has over two decades of global clinical development experience, including 3 NDA approvals obtained in the US ad China and 2 NDA submissions currently undergoing regulatory review in the US, an extensive experience in pre-clinical research and medical/commercial strategy with over 50 publications in medical journals, book reviews, and conferences, and Hands-on experience in license evaluation/management and preparations for fundraising and IPO.

Simon earned a PhD in Neuroscience from Karolinska Institute in Sweden, MS in Neuropharmacology from CAMS and medical doctor degree from Jiangxi Medical University.